Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 19397.0 | 51 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 20070.5 | 68 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 28137.0 | 55 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 29552.0 | 63 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 5167.0 | 39 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 5626.5 | 86 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 16058.0 | 57 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | MMP-3 | 24668.0 | 63 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 753.0 | 68 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 1037.0 | 67 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 58.0 | 70 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 190.5 | 66 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 182.0 | 83 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 131.0 | 71 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 130.5 | 72 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 578.5 | 60 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 2844.0 | 35 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 3141.0 | 73 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 6528.0 | 78 | |
N2759 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 5991.0 | 48 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 208.5 | 86 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 324.0 | 83 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-3 | 3704.0 | 67 | |
N2586 | TNF-a | 100 | ng/mL | 3 | MMP-3 | 5382.0 | 79 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MMP-3 | 734.5 | 72 |